Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs
- PMID: 28013312
- PMCID: PMC5452286
- DOI: 10.1159/000453454
Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs
Abstract
Mycobacterium bovis bacille Calmette-Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB). BCG mimics M. tuberculosis (Mtb) in its persistence in the body and is used as a benchmark to compare new vaccine candidates. BCG was originally designed for mucosal vaccination, but comprehensive knowledge about its interaction with epithelium is currently lacking. We used primary airway epithelial cells (AECs) and a murine model to investigate the initial events of mucosal BCG interactions. Furthermore, we analysed the impact of the G-protein-coupled receptors (GPCRs), CXCR1 and CXCR2, in this process, as these receptors were previously shown to be important during TB infection. BCG infection of AECs induced GPCR-dependent Rac1 up-regulation, resulting in actin redistribution. The altered distribution of the actin cytoskeleton involved the MAPK signalling pathway. Blocking of the CXCR1 or CXCR2 prior to infection decreased Rac1 expression, and increased epithelial transcriptional activity and epithelial cytokine production. BCG infection did not result in epithelial cell death as measured by p53 phosphorylation and annexin. This study demonstrated that BCG infection of AECs manipulated the GPCRs to suppress epithelial signalling pathways. Future vaccine strategies could thus be improved by targeting GPCRs.
Keywords: Bacille Calmette-Guérin; G-protein-coupled receptors; Pulmonary tuberculosis.
© 2016 The Author(s) Published by S. Karger AG, Basel.
Figures






Similar articles
-
Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner.Mucosal Immunol. 2018 May;11(3):968-978. doi: 10.1038/mi.2017.80. Epub 2017 Sep 20. Mucosal Immunol. 2018. PMID: 28930287 Free PMC article.
-
Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.Eur J Immunol. 2014 Feb;44(2):440-9. doi: 10.1002/eji.201343887. Eur J Immunol. 2014. PMID: 24214530
-
Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin.PLoS One. 2016 Oct 10;11(10):e0164431. doi: 10.1371/journal.pone.0164431. eCollection 2016. PLoS One. 2016. PMID: 27723804 Free PMC article.
-
BCG - old workhorse, new skills.Curr Opin Immunol. 2017 Aug;47:8-16. doi: 10.1016/j.coi.2017.06.007. Epub 2017 Jul 15. Curr Opin Immunol. 2017. PMID: 28719821 Review.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
-
Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder.Biomedicines. 2022 Jun 8;10(6):1357. doi: 10.3390/biomedicines10061357. Biomedicines. 2022. PMID: 35740379 Free PMC article. Review.
-
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton.EMBO Rep. 2018 Jan;19(1):29-42. doi: 10.15252/embr.201744371. Epub 2017 Nov 15. EMBO Rep. 2018. PMID: 29141986 Free PMC article.
-
The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex.Front Immunol. 2021 Jan 22;11:623119. doi: 10.3389/fimmu.2020.623119. eCollection 2020. Front Immunol. 2021. PMID: 33552087 Free PMC article. Review.
-
Functional characterization of Vibrio alginolyticus T3SS regulator ExsA and evaluation of its mutant as a live attenuated vaccine candidate in zebrafish (Danio rerio) model.Front Vet Sci. 2022 Aug 8;9:938822. doi: 10.3389/fvets.2022.938822. eCollection 2022. Front Vet Sci. 2022. PMID: 37265802 Free PMC article.
-
P53 in the impaired lungs.DNA Repair (Amst). 2020 Nov;95:102952. doi: 10.1016/j.dnarep.2020.102952. Epub 2020 Aug 19. DNA Repair (Amst). 2020. PMID: 32846356 Free PMC article. Review.
References
-
- Barclay WR, Busey WM, Dalgard DW, Good RC, Janicki BW, Kasik JE, Ribi E, Ulrich CE, Wolinsky E. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guérin. Am Rev Respir Dis. 1973;107:351–358. - PubMed
-
- Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska natives: a 60-year follow-up study. JAMA. 2004;291:2086–2091. - PubMed
-
- Blok BA, Arts RJ, van Crevel R, Benn CS, Netea MG. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. J Leukoc Biol. 2015;98:347–356. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous